HomeCompareATRI vs MAIN

ATRI vs MAIN: Dividend Comparison 2026

ATRI yields 1.91% · MAIN yields 7.09%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAIN wins by $47.20M in total portfolio value
10 years
ATRI
ATRI
● Live price
1.91%
Share price
$459.92
Annual div
$8.80
5Y div CAGR
70.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$744.8K
Annual income
$498,113.36
Full ATRI calculator →
MAIN
Main Street Capital Corporation
● Live price
7.09%
Share price
$51.65
Annual div
$3.66
5Y div CAGR
72.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.95M
Annual income
$40,208,699.11
Full MAIN calculator →

Portfolio growth — ATRI vs MAIN

📍 MAIN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATRIMAIN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATRI + MAIN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATRI pays
MAIN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATRI
Annual income on $10K today (after 15% tax)
$162.64/yr
After 10yr DRIP, annual income (after tax)
$423,396.36/yr
MAIN
Annual income on $10K today (after 15% tax)
$602.32/yr
After 10yr DRIP, annual income (after tax)
$34,177,394.24/yr
At 15% tax rate, MAIN beats the other by $33,753,997.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATRI + MAIN for your $10,000?

ATRI: 50%MAIN: 50%
100% MAIN50/50100% ATRI
Portfolio after 10yr
$24.35M
Annual income
$20,353,406.24/yr
Blended yield
83.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MAIN right now

ATRI
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
26.0
Piotroski
6/9
MAIN
Analyst Ratings
2
Buy
11
Hold
Consensus: Hold
Price Target
$65.25
+26.3% upside vs current
Range: $60.00 — $70.00
Altman Z
1.7
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATRI buys
0
MAIN buys
0
No recent congressional trades found for ATRI or MAIN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATRIMAIN
Forward yield1.91%7.09%
Annual dividend / share$8.80$3.66
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR70.5%72.7%
Portfolio after 10y$744.8K$47.95M
Annual income after 10y$498,113.36$40,208,699.11
Total dividends collected$700.3K$46.82M
Payment frequencyquarterlymonthly
SectorStockBDC
Analyst consensusSellHold

Year-by-year: ATRI vs MAIN ($10,000, DRIP)

YearATRI PortfolioATRI Income/yrMAIN PortfolioMAIN Income/yrGap
1← crossover$11,026$326.23$12,464$1,223.78$1.4KMAIN
2$12,371$573.18$16,353$2,343.58$4.0KMAIN
3$14,262$1,024.75$23,105$4,724.42$8.8KMAIN
4$17,143$1,882.46$36,226$10,256.23$19.1KMAIN
5$21,948$3,605.53$65,426$24,707.64$43.5KMAIN
6$30,840$7,355.78$142,101$68,562.02$111.3KMAIN
7$49,469$16,469.85$388,521$228,799.95$339.1KMAIN
8$95,028$42,096.26$1,397,868$961,169.80$1.30MMAIN
9$230,536$128,855.34$6,884,663$5,313,459.69$6.65MMAIN
10$744,786$498,113.36$47,947,060$40,208,699.11$47.20MMAIN

ATRI vs MAIN: Complete Analysis 2026

ATRIStock

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Full ATRI Calculator →

MAINBDC

Main Street Capital Corporation is a business development company specializes in equity capital to lower middle market companies. The firm specializing in recapitalizations, management buyouts, refinancing, family estate planning, management buyouts, refinancing, industry consolidation, mature, later stage emerging growth. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides one stop financing alternatives within its lower middle market portfolio. It prefers to invest in air freight and logistics, auto components, building products, chemicals, commercial services, computers, construction and engineering, consumer finance, consumer services, electronic equipment, energy equipment and services, financial services, health care equipment, health care providers, hotels, restaurants, and leisure, internet software and services, IT Services, machinery, oil, gas and consumable fuels, paper and forest products, professional and industrial services, road and rail, software, specialty retail, telecommunication, consumer discretionary, energy, materials, technology, and transportation. The firm typically invests in lower middle market companies generally with annual revenues between $5 million and $300 million. It prefers to invest in ranging between $2 million and $75 million in equity investment and enterprise value in ranging between $3 million and $20 million. The firm typically prefers to invest in the range of $5 million and $50 million per transaction in debt investment value and in the range of $1 million and $20 million in annual EBITDA. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It takes 5 percent minority and up to 50 percent majority equity investments. Main Street Capital Corporation was founded in 2007 and is based in Houston, Texas with an additional office in Chojnów, Poland.

Full MAIN Calculator →
📬

Get this ATRI vs MAIN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATRI vs SCHDATRI vs JEPIATRI vs OATRI vs KOATRI vs ARCCATRI vs HTGCATRI vs GBDCATRI vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.